1,430
Views
55
CrossRef citations to date
0
Altmetric
Reviews

Emerging treatment for chronic migraine and refractory chronic migraine

, , , , , , , , , & show all
Pages 393-406 | Published online: 03 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Giorgio Lambru, Anna P. Andreou, Martina Guglielmetti & Paolo Martelletti. (2018) Emerging drugs for migraine treatment: an update. Expert Opinion on Emerging Drugs 23:4, pages 301-318.
Read now
Bianca Raffaelli, Heike Israel, Lars Neeb & Uwe Reuter. (2017) The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opinion on Pharmacotherapy 18:13, pages 1409-1415.
Read now
Peiwei Hong & Yao Liu. (2017) Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis. International Journal of Neuroscience 127:1, pages 20-27.
Read now
Andrea Negro, Martina Curto, Luana Lionetto, Maria Adele Giamberardino & Paolo Martelletti. (2016) Chronic migraine treatment: from OnabotulinumtoxinA onwards. Expert Review of Neurotherapeutics 16:10, pages 1217-1227.
Read now
Abigail L. Chua & Stephen Silberstein. (2016) Inhaled drug therapy development for the treatment of migraine. Expert Opinion on Pharmacotherapy 17:13, pages 1733-1743.
Read now
Abdelaziz Ghanemi & Xintian Hu. (2015) Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies. Alexandria Journal of Medicine 51:4, pages 279-286.
Read now
Giovanna Gentile, Andrea Negro, Lidia D’Alonzo, Laura Aimati, Maurizio Simmaco, Paolo Martelletti & Marina Borro. (2015) Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population. Expert Review of Neurotherapeutics 15:2, pages 215-225.
Read now
Donata Sabato, Luana Lionetto & Paolo Martelletti. (2015) The therapeutic potential of novel anti-migraine acute therapies. Expert Opinion on Investigational Drugs 24:2, pages 141-144.
Read now
Maria Adele Giamberardino & Paolo Martelletti. (2015) Emerging drugs for migraine treatment. Expert Opinion on Emerging Drugs 20:1, pages 137-147.
Read now
Flavia Napoletano, Luana Lionetto & Paolo Martelletti. (2014) Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity. Expert Opinion on Pharmacotherapy 15:3, pages 303-305.
Read now
Doodipala Samba Reddy. (2013) The pathophysiological and pharmacological basis of current drug treatment of migraine headache. Expert Review of Clinical Pharmacology 6:3, pages 271-288.
Read now
Andrea Negro, Luana Lionetto, Lidia D'Alonzo, Barbara Casolla, Francesco Marsibilio, Gabriele Vignaroli, Maurizio Simmaco & Paolo Martelletti. (2013) Pharmacokinetic evaluation of almotriptan for the treatment of migraines. Expert Opinion on Drug Metabolism & Toxicology 9:5, pages 637-644.
Read now
Pablo Irimia, Mar Carmona-Abellán & Eduardo Martínez-Vila. (2012) Chronic migraine: a therapeutic challenge for clinicians. Expert Opinion on Emerging Drugs 17:4, pages 445-447.
Read now

Articles from other publishers (42)

Alaa S. Tulbah, Mohammed H. Elkomy, Randa Mohammed Zaki, Hussein M. Eid, Essam M. Eissa, Adel A. Ali, Heba A. Yassin, Basmah Nasser Aldosari, Ibrahim A. Naguib & Amira H. Hassan. (2023) Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures. International Journal of Pharmaceutics: X 6, pages 100206.
Crossref
Timothy E. McAlindon, Jeffrey B. Driban, Mary B. Roberts, Jeffrey Duryea, Ida K. Haugen, Lena F. Schaefer, Stacy E. Smith, Alexander Mathiessen & Charles Eaton. (2021) Erosive Hand Osteoarthritis: Incidence and Predictive Characteristics Among Participants in the Osteoarthritis Initiative. Arthritis & Rheumatology 73:11, pages 2015-2024.
Crossref
Daria Bongiovanni, Chiara Benedetto, Stefania Corvisieri, Claudia Del Favero, Fabio Orlandi, Gianni Allais, Silvia Sinigaglia & Maurizio Fadda. (2021) Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine. Neurological Sciences 42:9, pages 3865-3870.
Crossref
Dilek Cavusoglu, Nihal Olgac Dundar, Ozgur Oztekin, Pinar Arican, Pinar Gencpinar & Masallah Baran. (2021) A Neurological Appearance of Celiac Disease. Pediatric Emergency Care 37:6, pages 303-307.
Crossref
Alexey G. Voloshin & Irina V. Moiseeva. (2021) Combined Interventional Treatment of Refractory Chronic Migraine. SN Comprehensive Clinical Medicine 3:6, pages 1320-1326.
Crossref
Jose De Andres, Giuseppe Luca Formicola, Ruben Rubio-Haro & Carmen De Andres-Serrano. (2021) Updated management of occipital nerve stimulator lead migration: case report of a technical challenge. Scandinavian Journal of Pain 21:2, pages 415-420.
Crossref
Joana Gonçalves, Gilberto Alves, Carla Fonseca, Andreia Carona, Joana Bicker, Amílcar Falcão & Ana Fortuna. (2021) Is intranasal administration an opportunity for direct brain delivery of lacosamide?. European Journal of Pharmaceutical Sciences 157, pages 105632.
Crossref
Mahsa Arzani, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Vahabizad, Paolo Martelletti, Amir Ghaemi, Simona Sacco & Mansoureh Togha. (2020) Gut-brain Axis and migraine headache: a comprehensive review. The Journal of Headache and Pain 21:1.
Crossref
Devahuti Rai Chaliha, Mauro Vaccarezza, Ryu Takechi, Virginie Lam, Eric Visser, Peter Drummond & John Charles Louis Mamo. (2020) A Paradoxical Vasodilatory Nutraceutical Intervention for Prevention and Attenuation of Migraine—A Hypothetical Review. Nutrients 12:8, pages 2487.
Crossref
Georgia Tsaousi, Chryssa Pourzitaki, Spyridon Siafis, Athanassios Kyrgidis, Vasilios Grosomanidis, Dimitrios Kouvelas & Georgios Papazisis. (2019) Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis. European Journal of Clinical Pharmacology 76:2, pages 161-174.
Crossref
Dustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, Matthew Sexson, Sriram Govindan, Eric M Pearlman, Shuu-Jiun Wang, Arif Khan & Sheena K Aurora. (2019) Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure. Cephalalgia 39:8, pages 931-944.
Crossref
Lin Han, Yao Liu, Hai Xiong & Peiwei Hong. (2019) CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis. Brain and Behavior 9:2, pages e01215.
Crossref
Andrea Negro & Paolo Martelletti. 2019. Placebos and Nocebos in Headaches. Placebos and Nocebos in Headaches 13 25 .
Marco Annoni & Franklin G. Miller. 2019. Placebos and Nocebos in Headaches. Placebos and Nocebos in Headaches 135 142 .
Elif Ilgaz Aydinlar, Pinar Yalinay Dikmen, Seda Kosak & Ayse Sagduyu Kocaman. (2017) OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study. The Journal of Headache and Pain 18:1.
Crossref
Antonio Santoro, Andrea Fontana, Anna M. Miscio, Michele M. Zarrelli, Massimiliano Copetti & Maurizio A. Leone. (2017) Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting. Neurological Sciences 38:10, pages 1779-1789.
Crossref
Giannapia Affaitati, Paolo Martelletti, Mariangela Lopopolo, Claudio Tana, Francesca Massimini, Francesco Cipollone, Domenico Lapenna, Maria Adele Giamberardino & Raffaele Costantini. (2017) Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Practice 17:3, pages 392-401.
Crossref
Cinzia Costa, Paola Sarchielli, Paolo Prontera, Stefano Caproni & Josemir W. Sander. 2017. Comorbidities in Headache Disorders. Comorbidities in Headache Disorders 41 63 .
Martina Curto, Luana Lionetto, Andrea Negro, Matilde Capi, Francesco Fazio, Maria Adele Giamberardino, Maurizio Simmaco, Ferdinando Nicoletti & Paolo Martelletti. (2016) Altered kynurenine pathway metabolites in serum of chronic migraine patients. The Journal of Headache and Pain 17:1.
Crossref
Yi-Cheng Hou & Chien-Han Lai. (2016) The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report. Clinical Psychopharmacology and Neuroscience 14:4, pages 405-406.
Crossref
Laura Petrarca & Raffaella Nenna. (2016) Headache and Celiac Disease: An Increasingly Investigated Association. Headache: The Journal of Head and Face Pain 56:9, pages 1520-1521.
Crossref
TM Kinfe, B Pintea, S Roeske, Á Güresir, E Güresir & H Vatter. (2015) Percutaneous nerve field stimulation (PENS) of the occipital region as a possible predictor for occipital nerve stimulation (ONS) responsiveness in refractory headache disorders? A feasibility study. Cephalalgia 36:8, pages 779-789.
Crossref
Raffaella Nenna, Laura Petrarca, Paola Verdecchia, Matteo Florio, Nicoletta Pietropaoli, Gerarda Mastrogiorgio, Maria Bavastrelli, Margherita Bonamico & Salvatore Cucchiara. (2016) Celiac disease in a large cohort of children and adolescents with recurrent headache: A retrospective study. Digestive and Liver Disease 48:5, pages 495-498.
Crossref
Abdulkadir Koçer. (2016) Greater occipital nerve blocks in the treatment of refractory chronic migraine: An observational report of nine cases. World Journal of Clinical Cases 4:10, pages 323.
Crossref
Soo-Jin Cho, Tae-Jin Song & Min Kyung Chu. (2015) Outcome of Chronic Daily Headache or Chronic Migraine. Current Pain and Headache Reports 20:1.
Crossref
Luana Lionetto, Andrea Negro & Paolo Martelletti. 2016. Pharmacological Management of Headaches. Pharmacological Management of Headaches 19 29 .
Andrea Negro, Martina Curto, Luana Lionetto & Paolo Martelletti. (2016) A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience. The Journal of Headache and Pain 17:1.
Crossref
Maria Adele Giamberardino, Dimos-Dimitrios Mitsikostas & Paolo Martelletti. (2015) Update on Medication-Overuse Headache and Its Treatment. Current Treatment Options in Neurology 17:8.
Crossref
Uwe Reuter, Heike Israel & Lars Neeb. (2014) The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine. Therapeutic Advances in Neurological Disorders 8:1, pages 46-54.
Crossref
Andrea Negro & Paolo Martelletti. 2015. Case-Based Diagnosis and Management of Headache Disorders. Case-Based Diagnosis and Management of Headache Disorders 29 34 .
Roberto Arcioni & Paolo Martelletti. 2015. Case-Based Diagnosis and Management of Headache Disorders. Case-Based Diagnosis and Management of Headache Disorders 75 80 .
Paolo Martelletti, Zaza Katsarava, Christian Lampl, Delphine Magis, Lars Bendtsen, Andrea Negro, Michael Bjørn Russell, Dimos-Dimitrios D Mitsikostas & Rigmor Højland Jensen. (2014) Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation. The Journal of Headache and Pain 15:1.
Crossref
Brian E Cairns & Parisa Gazerani. (2014) Botulinum neurotoxin A for chronic migraine headaches: does it work and how?. Pain Management 4:6, pages 377-380.
Crossref
Kegang Cao, Lihua Yu, Ying Gao, Yongping Fan, Jianjun Zhao, Xuezhi Zhang, Wei Xie, Wenming Yang, Mengjiu Dong, Tao Li & Xiangyang Qiao. (2014) Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study. European Journal of Integrative Medicine 6:3, pages 259-267.
Crossref
Stephen J. Peroutka. (2014) Calcitonin Gene-Related Peptide Targeted Immunotherapy for Migraine: Progress and Challenges in Treating Headache. BioDrugs 28:3, pages 237-244.
Crossref
Stephan Feistel, Stephanie Albrecht & Karl Messlinger. (2013) The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion. The Journal of Headache and Pain 14:1.
Crossref
Paolo Martelletti, Rigmor H Jensen, Andrea Antal, Roberto Arcioni, Filippo Brighina, Marina de Tommaso, Angelo Franzini, Denys Fontaine, Max Heiland, Tim P Jürgens, Massimo Leone, Delphine Magis, Koen Paemeleire, Stefano Palmisani, Walter Paulus & Arne May. (2013) Neuromodulation of chronic headaches: position statement from the European Headache Federation. The Journal of Headache and Pain 14:1.
Crossref
Stefano Palmisani, Adnan Al-Kaisy, Roberto Arcioni, Tom Smith, Andrea Negro, Giorgio Lambru, Vijay Bandikatla, Eleanor Carson & Paolo Martelletti. (2013) A six year retrospective review of occipital nerve stimulation practice - controversies and challenges of an emerging technique for treating refractory headache syndromes. The Journal of Headache and Pain 14:1.
Crossref
Aynur ?zge. (2013) Chronic Daily Headache in the Elderly. Current Pain and Headache Reports 17:12.
Crossref
Alex Rodrigo Espinoza Giacomozzi, Alexander Parajeles Vindas, Ariovaldo Alberto da Silva Junior, Carlos Alberto Bordini, Carlos Federico Buonanotte, Célia Aparecida de Paula Roesler, Cláudio Manoel Brito, Cristina Perez, Deusvenir de Souza Carvalho, Djacir Dantas Pereira de Macedo, Elcio Juliato Piovesan, Elder Machado Sarmento, Eliana Meire Melhado, Fabíola Dach Éckeli, Fernando Kowacs, Fidel Sobrino, Getúlio Daré Rabello, Grisel Rada, Jano Alves de Souza, Juana Rosa Casanovas, Juan Carlos Durán, Leandro Cotoni Calia, Luis Roberto Partida Medina, Luiz Paulo de Queiroz, Marcelo Cedrinho Ciciarelli, Marcelo Moraes Valença, Maria Cusicanqui, Maria Karina Velez Jimenez, Maria Tereza Goycochea, Mário Fernando Prieto Peres, Mario Victor Fuentealba Sandoval, Maurice Borges Vincent, Michel Volcy Gomes, Mónica Diez, Nayeska Aranaga, Nelson Barrientos, Pedro André Kowacs & Pedro Ferreira Moreira Filho. (2013) Latin American consensus on guidelines for chronic migraine treatment. Arquivos de Neuro-Psiquiatria 71:7, pages 478-486.
Crossref
Yuka Watanabe, Ryotaro Takashima, Hisatake Iwanami, Shiho Suzuki, Hisaka Igarashi & Koichi Hirata. (2013) Management of chronic migraine in Japan. Rinsho Shinkeigaku 53:11, pages 1228-1230.
Crossref
Luigi Alberto Pini, Simona Guerzoni, Maria Michela Cainazzo, Anna Ferrari, Paola Sarchielli, Ilaria Tiraferri, Michela Ciccarese & Maurizio Zappaterra. (2012) Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. The Journal of Headache and Pain 13:8, pages 677-684.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.